Anmol Drugs & Pharmaceuticals Ltd
₹
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2006 | |
|---|---|
| 0.00 | |
| 0.02 | |
| Operating Profit | -0.02 |
| OPM % | |
| 0.04 | |
| Interest | 0.02 |
| Depreciation | 0.01 |
| Profit before tax | -0.01 |
| Tax % | 0.00% |
| -0.01 | |
| EPS in Rs | |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2006 | |
|---|---|
| Equity Capital | 6.66 |
| Reserves | -8.05 |
| 0.19 | |
| 1.54 | |
| Total Liabilities | 0.34 |
| 0.20 | |
| CWIP | 0.00 |
| Investments | 0.00 |
| 0.14 | |
| Total Assets | 0.34 |
Cash Flows
Figures in Rs. Crores
| Mar 2006 | |
|---|---|
| Net Cash Flow | |
| Free Cash Flow | |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Mar 2006 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Documents
Announcements
No data available.
Annual reports
No data available.